The competition is no longer just about better algorithms. It is about which nation, or which bloc, will set the standards, own the infrastructure, and…
For biotech and technology companies that rely on offshore structures for financing and listing, China’s more stringent regulatory posture signals a structural shift in how…
China’s push for chip self-reliance takes a practical turn as Alibaba launches an open-source processor designed for the next wave of artificial intelligence. Alibaba Group…
As the US-China technology rivalry deepens, the race for next-generation AI infrastructure is turning away from conventional chips. A Shanghai startup’s impending Hong Kong listing…
Three decades of parallel biotech ambition have left Hong Kong trailing Singapore by a significant distance. Yet the emergence of the Greater Bay Area offers…
While the global race for quantum computing leadership intensifies, China is signalling a strategic pivot: embedding advanced technologies like quantum communication and artificial intelligence into…
As geopolitical friction deepens and demand for next-generation computing surges, China’s push into alternative AI hardware architectures is no longer a laboratory curiosity. The imminent…
For global biotech investors and pharmaceutical strategists, the lesson is clear: China’s life sciences future is increasingly a story of regional ecosystems, not just national…
For global investors and technology executives, Beijing’s long-term blueprint signals that China is not merely catching up in frontier technologies but is building the industrial…
As conventional chip architectures face diminishing returns, photonic computing offers a path forward for AI workloads — and Chinese companies are moving swiftly to commercialise…
No products in the cart.
